Search results for "fusion"

showing 10 items of 4513 documents

From Feynman–Kac formulae to numerical stochastic homogenization in electrical impedance tomography

2016

In this paper, we use the theory of symmetric Dirichlet forms to derive Feynman–Kac formulae for the forward problem of electrical impedance tomography with possibly anisotropic, merely measurable conductivities corresponding to different electrode models on bounded Lipschitz domains. Subsequently, we employ these Feynman–Kac formulae to rigorously justify stochastic homogenization in the case of a stochastic boundary value problem arising from an inverse anomaly detection problem. Motivated by this theoretical result, we prove an estimate for the speed of convergence of the projected mean-square displacement of the underlying process which may serve as the theoretical foundation for the de…

65C05Statistics and Probability65N21stochastic homogenizationquantitative convergence result01 natural sciencesHomogenization (chemistry)78M40general reflecting diffusion process010104 statistics & probabilitysymbols.namesakeFeynman–Kac formula60J4535Q60Applied mathematicsFeynman diagramBoundary value problemSkorohod decomposition0101 mathematicsElectrical impedance tomographyBrownian motionMathematicsrandom conductivity field65N75010102 general mathematicsFeynman–Kac formulaLipschitz continuityBounded functionstochastic forward problemsymbols60J55Statistics Probability and Uncertainty60H30electrical impedance tomographyThe Annals of Applied Probability
researchProduct

Evolución y distribución sectorial de las fusiones de empresas españolas

2000

Es evidente que los procedimientos de fusión han sido empleados por las empresas españolas como estrategias para afrontar los retos competitivos en sus diferentes entornos económicos y, aunque han sido estudiados sus causas y resultados; el impacto global en el contexto de la economía española y su utilización real no han sido suficientemente investigados, sobre todo, debido a la falta de bases estadísticas apropiadas. En este trabajo, partiendo de la información de las últimas dos décadas, se analiza cuál ha sido su empleo efectivo, características y evolución, así como aquellos sectores más intensamente afectados. Para obtener una base que permita vislumbrar las posibles tendencias futura…

:CIENCIAS ECONÓMICAS::Economía general [UNESCO]EspañaReestructuración empresarialFusiones; Adquisiciones; Reestructuración empresarial; España; 1980-19981980-1998FusionesUNESCO::CIENCIAS ECONÓMICAS::Economía generalAdquisiciones
researchProduct

Overview of the JET preparation for deuterium-tritium operation with the ITER like-wall

2019

Documento escrito por un elevado número de autores/as, sólo se referencia el/la que aparece en primer lugar y los/as autores/as pertenecientes a la UC3M For the past several years, the JET scientific programme (Pamela et al 2007 Fusion Eng. Des. 82 590) has been engaged in a multi-campaign effort, including experiments in D, H and T, leading up to 2020 and the first experiments with 50%/50% D–T mixtures since 1997 and the first ever D–T plasmas with the ITER mix of plasma-facing component materials. For this purpose, a concerted physics and technology programme was launched with a view to prepare the D–T campaign (DTE2). This paper addresses the key elements developed by the JET programme d…

:Física [Ciências exactas e naturais]Nuclear engineeringPLASMASCONFINEMENTfusion power7. Clean energy01 natural sciences010305 fluids & plasmaslaw.inventionlawTRANSPORT EXPERIMENTSFusió nuclearMODESettore FIS/01Jet (fluid)fusion power ; JET ; tritium ; isotopeILW DIVERTORIsotopetritiumPhysicsSettore ING-IND/18 - Fisica dei Reattori NuclearimodeInjectorCondensed Matter PhysicsFusion Plasma and Space PhysicsSettore ING-IND/20 - Misure e Strumentazione Nucleariconfinementperformance[PHYS.PHYS.PHYS-FLU-DYN]Physics [physics]/Physics [physics]/Fluid Dynamics [physics.flu-dyn]Nuclear and High Energy PhysicsTechnology and Engineeringfusion power; JET; tritium; isotopetransport experimentsPlasma (Gasos ionitzats)Tritium114 Physical sciencesFísica FísicaFusion plasma och rymdfysik:Physical sciences [Natural sciences]0103 physical sciencesThermalFusion powerFusiónNeutronddc:530010306 general physicsisotopePhysics Physical sciencesQC717fusion power; isotope; JET; tritiumPlasma (Ionized gases)Spectrometer:Física [Àrees temàtiques de la UPC]FísicaPlasmaFusion powerPERFORMANCEplasmasilw divertorHigh-confinement mode13. Climate actionJetJETEnvironmental scienceNuclear fusion
researchProduct

Observation and Measurement of Forward Proton Scattering in Association with Lepton Pairs Produced via the Photon Fusion Mechanism at ATLAS

2020

The observation of forward proton scattering in association with lepton pairs (eþe− þ p or μþμ− þ p) produced via photon fusion is presented. The scattered proton is detected by the ATLAS Forward Proton spectrometer, while the leptons are reconstructed by the central ATLAS detector. Proton-proton collision data recorded in 2017 at a center-of-mass energy of ffiffiffi s p ¼ 13 TeV are analyzed, corresponding to an integrated luminosity of 14.6 fb−1. A total of 57 (123) candidates in the ee þ p (μμ þ p) final state are selected, allowing the background-only hypothesis to be rejected with a significance exceeding 5 standard deviations in each channel. Proton-tagging techniques are introduced f…

:Kjerne- og elementærpartikkelfysikk: 431 [VDP]Photon13000 GeV-cmsLHC ATLASmeasured [channel cross section]General Physics and Astronomy01 natural sciences7. Clean energyHigh Energy Physics - Experimentelectron: pair productionSubatomär fysikHigh Energy Physics - Experiment (hep-ex)Integrated LuminosityFusion Mechanismphoton photon: fusionspectrometer [p]Subatomic Physics[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]scattering [p p]pair production [lepton]Electroweak interactionQuantum ChromodynamicsParticle productionNuclear ExperimentSettore FIS/01PhysicsQuantum chromodynamicsObservation and MeasurementQuantum electrodynamicsLarge Hadron Colliderp: spectrometerdimuonAtlas (topology)COLLISIONS; PHYSICS; GAMMA; LIGHT; LHCElectroweak interactionDetectorphotonATLASfusion [photon photon]muon: pair production:Nuclear and elementary particle physics: 431 [VDP]PhotoproductionLIGHTCERN LHC CollATLAS DetectorsLHCcolliding beams [p p]channel cross section: measuredParticle Physics - Experimentsmall-angleParticle physicsp p: scatteringCOLLISIONSp: particle identificationCiências Naturais::Ciências Físicas530 Physicslepton: pair production:Ciências Físicas [Ciências Naturais]Particles & FieldsFOS: Physical sciencesparticle identification [p]LHC ATLAS High Energy PhysicsPHYSICS0103 physical sciencesddc:530Cross-Section Measurementpair production [electron]pair production [muon]High Energy Physics010306 general physicsCiencias ExactasATLAS CollaborationScience & TechnologySpectrometerhep-exPomeronsFísicaGAMMALeptonsProton Scatteringexclusive productionPrecision measurementsProton Proton CollisionsStandard DeviationExperimental High Energy PhysicsElementary Particles and FieldsHigh Energy Physics::ExperimentHadron-hadron collisionsp p: colliding beamsLeptonacceptanceexperimental results
researchProduct

Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy in vitro and in vivo

2021

Multidrug resistance (MDR) mediated by ATP binding cassette subfamily B member 1 (ABCB1) is significantly hindering effective cancer chemotherapy. However, currently, no ABCB1-inhibitory drugs have been approved to treat MDR cancer clinically, mainly due to the inhibitor specificity, toxicity, and drug interactions. Here, we reported that three polyoxypregnanes (POPs) as the most abundant constituents of Marsdenia tenacissima (M. tenacissima) were novel ABCB1-modulatory pro-drugs, which underwent intestinal microbiota-mediated biotransformation in vivo to generate active metabolites. The metabolites at non-toxic concentrations restored chemosensitivity in ABCB1-overexpressing cancer cells v…

ABCC1 ATP binding cassette subfamily C member 1IC50 half maximal inhibitory concentrationMultidrug resistancePharmacologyNADPH reduced nicotinamide adenine dinucleotide phosphateF bioavailabilitychemistry.chemical_compoundPCR polymerase chain reaction0302 clinical medicineMDR multidrug resistanceECL electrochemiluminescencet1/2 elimination half-lifeLC–MS liquid chromatography coupled with mass spectrometryN.D. not detectedGeneral Pharmacology Toxicology and PharmaceuticsBBB blood–brain barriermedia_commonATF3 activating transcription factor 30303 health sciencesChemistryABC ATP-binding cassetteNMPA National Medical Products AdministrationPXR pregnane X receptorSDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresisHBSS Hankʹs balanced salt solutionABCB1Combination chemotherapyProdrugMarsdenia tenacissimaCmax peak concentrationPaclitaxelGAPDH glyceraldehyde-3-phosphate dehydrogenase030220 oncology & carcinogenesisBHI brain heart infusionOriginal ArticleAUC0–∞ area under plasma concentration vs. time curveMRT mean residence timeDrugmedia_common.quotation_subjectRM1-950Vd volume of distributionABCB1 ATP binding cassette subfamily B member 1UIC-2 mouse monoclonal ABCB1 antibodyABCG2 ATP binding cassette subfamily G member 2Combination chemotherapyCYP cytochrome P450 isozymePI propidium iodideTEER transepithelial electrical resistance03 medical and health sciencesPBS phosphate buffer salineFBS fetal bovine serumDox doxorubicinIn vivoPOP polyoxypregnanemedicine030304 developmental biologyEVOM epithelial tissue voltohmmeterTmax time for peak concentrationCancerLBE lowest binding energyPE phycoerythrinmedicine.diseaseMultiple drug resistancePolyoxypregnanePapp apparent permeabilityN.A. not applicableCancer cellH&E hematoxylin and eosinMDR1a multidrug resistance protein 1aTherapeutics. PharmacologyqPCR quantitative PCRM. tenacissima Marsdenia tenacissimaCL clearanceSD standard derivationActa Pharmaceutica Sinica B
researchProduct

IDEAL study: A real‐world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX‐FP) i…

2022

Introduction: Factor IX replacement therapy is used for treatment and prophylaxis of bleeding in haemophilia B. rIX-FP is an extended half-life albumin-fusion protein, which, in clinical studies, has demonstrated prolonged dosing intervals up to 21 days for routine prophylaxis, providing therapeutic benefit.Aims: To describe dosing frequency and consumption (primary endpoint), efficacy and safety of rIX-FP treatment during routine clinical practice in Italy.Methods: Patients with moderate/severe haemophilia B on prophylaxis with rIX-FP for >= 6 months, were enrolled in this observational study from October 2017 to February 2019 and followed-up for 2 years. Descriptive analysis included p…

ABR Trough levels annual consumption extended half-life FIX infusion frequency real lifeHematologyGeneral MedicineGenetics (clinical)Haemophilia
researchProduct

In senescence accelerated mouse (SAM) heart, the protective effect of postconditioning is associated with a decrease in oxidative stress

2006

Supplément vol.27, World Congress of Cardiology 2006; International audience; The senescent heart susceptibility to ischemia (I) triggers multiple processes especially oxidative stress but precise mechanisms remain unclear. New animal’s models such as "Senescence Accelerated Mouse" Prone 8 (SAM-P8) and their control (SAM-R1) can be useful for a better understanding of aging process. We studied heart adaptation of these mice to I/reperfusion (R) sequence and a putative cardioprotector effect of post-conditioning (PC). Isolated working mice (8 months) hearts were subjected to a global total ischemia (20 minutes at 38°C), followed by 40 minutes of reperfusion. 4 groups of hearts were constitut…

AGING[SPI.GPROC] Engineering Sciences [physics]/Chemical and Process Engineering[SDV.IDA]Life Sciences [q-bio]/Food engineering[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringOXIDATIVE STRESSISCHEMIA/REPERFUSION[SDV.IDA] Life Sciences [q-bio]/Food engineering
researchProduct

Der gegenwärtige Stand der Blutfiltration - Grundlagen und klinische Bedeutung von Leukozytendepletions- und Mikroaggregatfiltern bei der Bluttransfu…

1993

In this review the role of the latest generation of leukodepletion blood filters and the adverse reaction of leukocytes i.e. alloimmunisation, immunosuppression, nonhaemolytic febrile transfusion reaction, platelet refractoriness, transmission of infectious agents are described and discussed. Leukocyte-poor blood component is indicated for patients with a history of nonhaemolytic febrile transfusion reaction, in avoiding alloimmunisation in patients waiting for transplantation or platelet refractoriness and in preventing CMV-infection. In the review the role of microaggregate filters in transfusion complications, namely, nonhaemolytic febrile transfusion reaction, thrombocytopenia, adult re…

ARDSBlood transfusionRespiratory distressbusiness.industrymedicine.medical_treatmentImmunosuppressionGeneral MedicineCritical Care and Intensive Care Medicinemedicine.diseaseBlood cellTransplantationAnesthesiology and Pain Medicinemedicine.anatomical_structureBlood productIntensive careImmunologyEmergency MedicinemedicinebusinessAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
researchProduct

Random allogeneic blood transfusion in pigs: characterisation of a novel experimental model.

2019

BackgroundOrgan cross-talk describes interactions between a primary affected organ and a secondarily injured remote organ, particularly in lung-brain interactions. A common theory is the systemic distribution of inflammatory mediators that are released by the affected organ and transferred through the bloodstream. The present study characterises the baseline immunogenic effects of a novel experimental model of random allogeneic blood transfusion in pigs designed to analyse the role of the bloodstream in organ cross-talk.MethodsAfter approval of the State and Institutional Animal Care Committee, 20 anesthetized pig were randomized in a donor and an acceptor (eachn = 8): the acceptor animals …

ARDSmedicine.medical_specialtyBlood transfusionEmergency and Critical Caremedicine.medical_treatmentSurgery and Surgical Specialtieslcsh:MedicineInflammation030204 cardiovascular system & hematologyGeneral Biochemistry Genetics and Molecular BiologyPulmonary function testing03 medical and health sciences0302 clinical medicinemedicineExperimental modelAdverse effectRespiratory MedicineCrosstalkLungAnesthesiology and Pain ManagementWhole bloodInflammationLungbusiness.industryTransfusionGeneral Neurosciencelcsh:RBrain030208 emergency & critical care medicineHematologyGeneral Medicinemedicine.diseaseBloodPig modellmedicine.anatomical_structureAnesthesiaARDSHistopathologymedicine.symptomGeneral Agricultural and Biological SciencesbusinessPeerJ
researchProduct

CitA/CitB Two-Component System Regulating Citrate Fermentation in Escherichia coli and Its Relation to the DcuS/DcuR System In Vivo

2011

ABSTRACT Citrate fermentation by Escherichia coli requires the function of the citrate/succinate antiporter CitT ( citT gene) and of citrate lyase ( citCDEFXG genes). Earlier experiments suggested that the two-component system CitA/CitB, consisting of the membrane-bound sensor kinase CitA and the response regulator CitB, stimulates the expression of the genes in the presence of citrate, similarly to CitA/CitB of Klebsiella pneumoniae . In this study, the expression of a chromosomal citC-lacZ gene fusion was shown to depend on CitA/CitB and citrate. CitA/CitB is related to the DcuS/DcuR two-component system which induces the expression of genes for fumarate respiration in response to C 4 -di…

ATP citrate lyaseOperonBiologymedicine.disease_causeMicrobiologyCitric AcidFusion geneGene clusterEscherichia colimedicinePromoter Regions GeneticMolecular BiologyEscherichia coliEscherichia coli ProteinsPromoterGene Expression Regulation BacterialArticlesMolecular biologyTwo-component regulatory systemDNA-Binding ProteinsResponse regulatorBiochemistryFermentationProtein KinasesProtein BindingTranscription FactorsJournal of Bacteriology
researchProduct